Stock listing

UNCY Stock Price, News, Filings & Events — Unicycive Therapeutics, Inc.

Selected listing: UNCY · NASDAQ · USD · US

This page tracks Unicycive Therapeutics, Inc.'s UNCY:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following UNCY:NASDAQ. UNCY:NASDAQ is the stock-level entry point for investors researching Unicycive Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Unicycive Therapeutics, Inc. is a public company traded under the ticker UNCY in the American market. The company has a market capitalization of approximately $144.2 million. Unicycive focuses on developing innovative therapies to address unmet medical needs.

UNCY:NASDAQUSDUSUpdated August 31, 2026
Unicycive Therapeutics, Inc. logo
Ticker
UNCY:NASDAQ
Asset type
Stock
Market cap
$146.7M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Unicycive Therapeutics, Inc. UNCY:NASDAQ stock context

This page tracks Unicycive Therapeutics, Inc.'s UNCY:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following UNCY:NASDAQ. UNCY:NASDAQ is the stock-level entry point for investors researching Unicycive Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Unicycive Therapeutics, Inc. is a public company traded under the ticker UNCY in the American market. The company has a market capitalization of approximately $144.2 million. Unicycive focuses on developing innovative therapies to address unmet medical needs.

Latest news from Unicycive Therapeutics, Inc.

All Unicycive Therapeutics, Inc. news →

Research Unicycive Therapeutics, Inc.

Alternate listings